Asymmetric Dimethylarginine Plasma Levels and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients

It is now well established that major risk factors for cardiovascular diseases (CVD) impact upon endothelial function by decreasing nitric oxide (NO) bioavailability. Asymmetric dimethylarginine (ADMA), an endogenous analog of l-arginine, is able to inhibit the activity of endothelial-NO synthase, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sciacqua, Angela, Grillo, Nadia, Quero, Michele, Sesti, Giorgio, Perticone, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509551/
https://www.ncbi.nlm.nih.gov/pubmed/23203035
http://dx.doi.org/10.3390/ijms131113804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509551/
https://www.ncbi.nlm.nih.gov/pubmed/23203035
http://dx.doi.org/10.3390/ijms131113804

Ejemplares similares